Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Prepaid Assets (2021 - 2026)

Centessa Pharmaceuticals has reported Prepaid Assets over the past 5 years, most recently at $1.8 million for Q4 2025.

  • Quarterly Prepaid Assets rose 22.21% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 22.21% year-over-year, with the annual reading at $1.8 million for FY2025, 22.21% up from the prior year.
  • Prepaid Assets was $1.8 million for Q4 2025 at Centessa Pharmaceuticals, down from $2.8 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $22.7 million in Q3 2023 and troughed at $1.1 million in Q1 2022.
  • The 5-year median for Prepaid Assets is $2.7 million (2024), against an average of $8.1 million.
  • The largest YoY upside for Prepaid Assets was 1658.77% in 2023 against a maximum downside of 91.87% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $18.3 million in 2021, then rose by 8.95% to $19.9 million in 2022, then plummeted by 91.87% to $1.6 million in 2023, then fell by 7.77% to $1.5 million in 2024, then grew by 22.21% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Prepaid Assets are $1.8 million (Q4 2025), $2.8 million (Q3 2025), and $1.6 million (Q2 2025).